IL268680B - 3'diamino-3'-(2"-pyrroline-1"-yl)-5-imino-13-dioxyanthracyclines and preparation method - Google Patents

3'diamino-3'-(2"-pyrroline-1"-yl)-5-imino-13-dioxyanthracyclines and preparation method

Info

Publication number
IL268680B
IL268680B IL268680A IL26868019A IL268680B IL 268680 B IL268680 B IL 268680B IL 268680 A IL268680 A IL 268680A IL 26868019 A IL26868019 A IL 26868019A IL 268680 B IL268680 B IL 268680B
Authority
IL
Israel
Prior art keywords
deoxyanthracyclines
deamino
pyrroline
imino
preparation
Prior art date
Application number
IL268680A
Other languages
English (en)
Hebrew (he)
Other versions
IL268680A (en
Original Assignee
Monopar Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monopar Therapeutics Inc filed Critical Monopar Therapeutics Inc
Publication of IL268680A publication Critical patent/IL268680A/en
Publication of IL268680B publication Critical patent/IL268680B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL268680A 2017-02-16 2019-08-13 3'diamino-3'-(2"-pyrroline-1"-yl)-5-imino-13-dioxyanthracyclines and preparation method IL268680B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/434,617 US10450340B2 (en) 2017-02-16 2017-02-16 3′-deamino-3′-(2″-pyrroline-1″-yl)-5-imino-13-deoxyanthracyclines and methods of preparation
PCT/US2018/000090 WO2018151872A1 (en) 2017-02-16 2018-02-16 3'deamino-3'-(2"-pyrroline-1"-yl)-5-imino-13-deoxyanthracyclines and methods of preparation

Publications (2)

Publication Number Publication Date
IL268680A IL268680A (en) 2019-10-31
IL268680B true IL268680B (en) 2022-02-01

Family

ID=61692048

Family Applications (1)

Application Number Title Priority Date Filing Date
IL268680A IL268680B (en) 2017-02-16 2019-08-13 3'diamino-3'-(2"-pyrroline-1"-yl)-5-imino-13-dioxyanthracyclines and preparation method

Country Status (11)

Country Link
US (1) US10450340B2 (https=)
EP (1) EP3582788A1 (https=)
JP (1) JP7159177B2 (https=)
KR (1) KR20190117609A (https=)
CN (1) CN110573165B (https=)
AU (1) AU2018220520A1 (https=)
BR (1) BR112019017166A2 (https=)
CA (1) CA3053417A1 (https=)
IL (1) IL268680B (https=)
MX (1) MX388090B (https=)
WO (1) WO2018151872A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843903A (en) 1995-11-27 1998-12-01 The Administrators Of The Tulane Educational Fund Targeted cytotoxic anthracycline analogs
US5948896A (en) 1997-08-13 1999-09-07 Gem Pharmaceuticals Processes for preparing 13-deoxy anthracycline derivatives
US5942605A (en) 1998-03-03 1999-08-24 Gem Pharmaceuticals, Inc. 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them
US7244829B2 (en) 2004-11-08 2007-07-17 Gem Pharmaceuticals, Llc Compositions and processes for preparing 13-deoxy-anthracyclines
JP2007261976A (ja) 2006-03-28 2007-10-11 Meiji Seika Kaisha Ltd 抗腫瘍性アンスラサイクリン系抗生物質の製造法
US7776832B2 (en) 2006-04-21 2010-08-17 Gem Pharmaceuticals, Llc Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
US9904704B2 (en) 2014-04-22 2018-02-27 Openx Software Limited System and method for controlling audience data and tracking

Also Published As

Publication number Publication date
MX388090B (es) 2025-03-19
RU2019128837A3 (https=) 2021-06-17
BR112019017166A2 (pt) 2020-04-14
US20180230175A1 (en) 2018-08-16
MX2019009733A (es) 2020-02-07
AU2018220520A1 (en) 2019-09-05
CN110573165A (zh) 2019-12-13
CA3053417A1 (en) 2018-08-23
EP3582788A1 (en) 2019-12-25
CN110573165B (zh) 2023-07-11
JP7159177B2 (ja) 2022-10-24
JP2020507608A (ja) 2020-03-12
RU2019128837A (ru) 2021-03-16
KR20190117609A (ko) 2019-10-16
IL268680A (en) 2019-10-31
US10450340B2 (en) 2019-10-22
WO2018151872A1 (en) 2018-08-23

Similar Documents

Publication Publication Date Title
IL274276A (en) CASZ preparations and methods of use
GB2582100B (en) CAS12C Compositions and methods of use
ZA201905677B (en) Glycan-interacting compounds and methods of use
IL256621A (en) Carrier-binder preparations and methods for their preparation and use
PL3548033T3 (pl) Związki i sposoby ich stosowania
ZA201906169B (en) Synthekine compositions and methods of use
IL266047A (en) Methods and preparations for the treatment of Fabry disease
PL3675801T3 (pl) Cząstki przeciwdrobnoustrojowe i sposoby ich stosowania
IL265870A (en) Nanoparticle formulations and methods of making and using thereof
GB201519128D0 (en) Solid forms and methods of preparing the same
GB2555248B (en) Artificial placenta and methods of preparation
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
IL265955A (en) Therapeutic compounds and methods of using them
IL266132A (en) Pharmacological formulations and methods for their preparation
IL258139A (en) Nicotine compositions and methods for their preparation and use
IL266345A (en) Dihydropyrimidine compound and method of preparation and use thereof
IL275739A (en) Preparations for cryopreservation and methods of their use
IL250289B (en) Antibodies against angiopoietin-like 4 and methods of use
PL3277287T3 (pl) Mieszaniny oligosacharydów mleka ludzkiego zawierające 3'-O-sialilolaktozę
ZA201906326B (en) Analogs of deutetrabenazine, their preparation and use
EP3563861C0 (en) NANOPARTICLE DERIVED FROM GINSENG AND ASSOCIATED PREPARATION AND APPLICATION
PT3408287T (pt) Gdf15 em glaucoma e respetivos métodos de utilização
SG10201606557RA (en) Oxygen-enriched water composition, biocompatible composition comprising the same, and methods of preparing and using the same
IL261794A (en) Preparations and methods for using them
IL268680B (en) 3'diamino-3'-(2"-pyrroline-1"-yl)-5-imino-13-dioxyanthracyclines and preparation method